Indefinite Delivery Contract 75N95019D00026

The National Institute of Neurological Disorders and Stroke (NINDS), a civilian federal agency, has awarded Psychogenics Inc., a for-profit preclinical contract research organization, a $69.1 million cost-plus-fixed-fee delivery order contract to provide screening of investigational agents through the NINDS Preclinical Screening Platform for Pain (PSPP) program. This delivery order is part of a larger $49.9 million single-award indefinite delivery contract between NINDS and Psychogenics to...

The National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health (NIH), has awarded Advanced Bioscience Laboratories, Inc. (ABL), a foreign-owned, for-profit manufacturer of goods, an Indefinite Delivery Contract (IDC) valued at $149.2 million. The purpose of this contract is to provide manufacturing and nonclinical studies support for the development of therapeutic biotechnology products for neurological-related disorders. Under this IDC, NINDS...

The National Institutes of Health National Institute of Neurological Disorders and Stroke awarded an indefinite-delivery/indefinite-quantity contract to the University of Illinois with a potential value of $174.47 million. The contract supports the Pharmacology and Toxicology for Therapeutics Program, which aims to advance promising new treatments through preclinical testing. Under the contract, the University of Illinois will provide management and operations support services, as well as...

This $49.9 million Indefinite Delivery Contract was awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to PPD Development LP, a global contract research organization (CRO) subsidiary of Thermo Fisher Scientific. The contract is for research and development related to clinical studies under NIDA's Blueprint MedTech program, which focuses on medical technology development for nervous system disorders. Under this IDC, PPD will provide a range of services including developing...

This indefinite delivery contract awarded by the National Institute on Drug Abuse (NIDA), a civilian federal agency, to PPD Development LP, a global contract research organization (CRO) subsidiary of Thermo Fisher Scientific, provides regulatory consulting assistance and research and development support for medical device development projects under the Blueprint MedTech (BPMT) program. The contract has a ceiling value of $24 million over a 5-year ordering period from September 2022 to...

The Department of Health and Human Services' National Institutes of Health (NIH) National Institute on Aging (NIA) awarded a $2,326,159.08 Indefinite Delivery Contract (IDC) to the prime contractor QPS Austria GmbH, a for-profit contract research organization. The IDC, which has a period of performance through May 31, 2025, is to provide experimental validation of candidate Alzheimer's disease treatments identified through multi-omics analyses under the NIA's Drug Repurposing for Effective...

The National Institutes of Health National Center for Advancing Translational Sciences awarded a multiple award indefinite delivery/indefinite quantity contract to MPF Federal, LLC to provide regulatory support services. Task orders issued to date under the contract include $649,000 for regulatory support relating to a detoxified form of botulinum neurotoxin as a treatment for chronic neuropathic pains focusing on osteoarthritis. An additional task order valued at $1,109,384.03 was awarded for...

The National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), has awarded an Indefinite Delivery Contract (IDC) to Actuated Medical, Inc., doing business as Piezo Resonance Innovations Inc. The $35 million, single-award IDC runs through September 2028 and is for research and development services related to biocompatibility testing, animal studies, and sterilization testing in support of NIDA's Blueprint MedTech (BPMT) Initiative. This work involves...

The National Institutes of Health National Institute of Neurological Disorders and Stroke awarded an indefinite-delivery/indefinite-quantity multiple award contract to Battelle Memorial Institute for Manufacturing and Nonclinical Studies Support for the Development of Therapeutic Biotechnology Products for Neurological-related Disorders. The original solicitation sought to procure manufacturing and nonclinical services over five years to support the development of biotechnology products for...

The National Institutes of Health (NIH) National Institute on Drug Abuse (NIDA) awarded a $6.5 million single-award Indefinite Delivery Contract (IDC) to the Lovelace Biomedical Research Institute, a not-for-profit contract research organization, to assess potential treatments for drug-induced respiratory depression and overdose toxicity. The contract has a period of performance from September 26, 2022 to September 25, 2027. Under this IDC, NIDA has issued several cost-plus-fixed-fee delivery...